LSM14A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.134600E-01
Normal-vs-Stage2
3.334200E-01
Normal-vs-Stage3
8.905800E-02
Normal-vs-Stage4
9.165200E-01
Stage1-vs-Stage2
9.104600E-01
Stage1-vs-Stage3
7.830300E-02
Stage1-vs-Stage4
1.043950E-01
Stage2-vs-Stage3
1.308760E-01
Stage2-vs-Stage4
3.182800E-01
Stage3-vs-Stage4
2.864200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.188200E-01
Normal-vs-AfricanAmerican
5.230800E-01
Normal-vs-Asian
2.225000E-01
Caucasian-vs-AfricanAmerican
7.715000E-01
Caucasian-vs-Asian
4.345200E-01
AfricanAmerican-vs-Asian
4.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.546400E-01
Normal-vs-Female
2.827200E-01
Male-vs-Female
9.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.775600E-01
Normal-vs-Age(41-60Yrs)
5.794000E-01
Normal-vs-Age(61-80Yrs)
2.648200E-01
Normal-vs-Age(81-100Yrs)
4.708500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.089200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.447400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.137800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.413630E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.990400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.653600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.239400E-01
Normal-vs-Daily Drinker
1.271020E-01
Normal-vs-Weekly Drinker
2.161800E-01
Normal-vs-Occasional Drinker
6.644000E-01
Normal-vs-Social Drinker
5.914600E-01
Non Drinker-vs-Daily Drinker
8.611800E-01
Non Drinker-vs-Weekly Drinker
9.852200E-01
Non Drinker-vs-Occasional Drinker
7.873900E-02
Non Drinker-vs-Social Drinker
3.111000E-01
Daily Drinker-vs-Weekly Drinker
8.590200E-01
Daily Drinker-vs-Occasional Drinker
4.090300E-02
Daily Drinker-vs-Social Drinker
2.371600E-01
Weekly Drinker-vs-Occasional Drinker
1.160000E-01
Weekly Drinker-vs-Social Drinker
3.935800E-01
Occasional Drinker-vs-Social Drinker
6.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.671800E-02
Normal-vs-Grade 2
1.079550E-02
Normal-vs-Grade 3
1.592340E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.419600E-01
Grade 1-vs-Grade 3
4.988400E-01
Grade 1-vs-Grade 4
8.671800E-02
Grade 2-vs-Grade 3
7.343400E-01
Grade 2-vs-Grade 4
1.079550E-02
Grade 3-vs-Grade 4
1.592340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.099600E-01
Normal-vs-NonDiabetic
2.629800E-01
Diabetic-vs-NonDiabetic
6.333800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.729200E-01
Normal-vs-NoPancreatitis
2.932400E-01
Pancreatitis-vs-NoPancreatitis
9.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.326200E-01
Normal-vs-N1
3.333400E-01
N0-vs-N1
8.611200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.456200E-01
Normal-vs-TP53-NonMutant
3.988200E-01
TP53-Mutant-vs-TP53-NonMutant
4.856300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
